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miR-223-3p promotes autoreactive Th17 cell responses
in experimental autoimmune uveitis (EAU) by inhibiting
transcription factor FOXO3 expression
Yankai Wei,*,1 Sisi Chen,*,1 Deming Sun,†,‡ Xue Li,* Ruihua Wei,* Xiaorong Li,*,2 and Hong Nian*,3
*Tianjin Key Laboratory of Retinal Functions and Diseases, Eye Institute and School of Optometry, Tianjin Medical University Eye Hospital,
Tianjin, China; †Department of Ophthalmology, David Geffen School of Medicine, University of California–Los Angeles, Los Angeles,
California, USA; and ‡Doheny Eye Institute, Los Angeles, California, USA
ABSTRACT: Pathogenic T helper (Th)17 cells are keymediators of autoimmunediseases such as uveitis and its animal
model, experimental autoimmune uveitis (EAU). However, the contribution of microRNAs (miRs) to the intrinsic
control of pathogenic Th17 cells in EAU remains largely unknown. Here, we have reported that miR-223-3p was
significantlyup-regulated in interphotoreceptor retinoid-bindingprotein–specificTh17 cells, and its expressionwas
enhanced by IL-23–signal transducer and activator of transcription 3 signaling. Knockdown of miR-223-3p de-
creased the pathogenicity of Th17 cells in a T-cell transfermodel of EAU.Mechanistic studies showed thatmiR-223-
3pdirectly repressed theexpressionof forkheadboxO3(FOXO3), andFOXO3negatively regulatedpathogenicTh17
cell responses partially via suppression of IL-23 receptor expression. Thus, our results reveal an important role for
miR-223-3p inautoreactiveTh17cell responsesandsuggest apotential therapeutic avenueforuveitis.—Wei,Y.,Chen,
S., Sun, D., Li, X., Wei, R., Li, X., Nian, H. miR-223-3p promotes autoreactive Th17 cell responses in experimental
autoimmune uveitis (EAU) by inhibiting transcription factor FOXO3 expression. FASEB J. 33, 13951–13965 (2019).
www.fasebj.org
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T helper (Th)17 cells are critically involved in the patho-
genesis of various autoimmune disorders, including uve-
itis and its animal model, experimental autoimmune
uveitis (EAU) (1–3). Th17 cells require IL-6 and TGF-b for
their development and IL-23 for their effector functions
(4–6). Increasing data demonstrate that Th17 cells induced
by IL-23 are more pathogenic than those induced by IL-6
and TGF-b (7). IL-23 stabilizes pathogenic Th17 cell phe-
notype by increasing expression of IL-23 receptor (IL-23R)
and endows Th17 cells with pathogenic effector functions
(8, 9). IL-23 also drives the expression of granulocyte-
macrophage colony-stimulating factor (GM-CSF) (10, 11),
which is crucial for the pathogenicity of Th17 cells. Al-
though much is known about the key factors that drive
Th17 cell differentiation and pathogenicity, very little is
known about the cell-intrinsic mechanisms that regulate
pathogenic function of Th17 cells.
MicroRNAs (miRs) are noncoding single-stranded
RNAs of about 22 nt that regulate gene expression at the
post-transcriptional level via translational repression or
mRNA degradation (12). miRs have been revealed to
control dynamic aspects of autoimmunity (13). Moreover,
published works have characterized a series of miRs in-
volved in uveitis pathogenesis (14–16). Regarding the role
ofmiRs in Th17 cells in uveitis, miR-155 has been shown to
promote Th17 responses by targeting E26 transformation
specific-1 (Ets-1) in CD4+ T cells from patients with active
Behçet’s disease (BD) (17). Furthermore, Chang et al. (18)
reported that miR-20a-5p suppressed Th17 cell responses
by targetingoncostatinMandC-Cmotif chemokine ligand
1 in CD4+ T cells in patients with active Vogt-Koyanagi-
Harada disease. However, the contributions of miRs to
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pathogenic Th17 cells induced by IL-23 in uveitis are still
largely unknown.
The forkheadboxO (FOXO) family (FOXO1,3, 4, and6)
of transcription factors plays important roles in innate and
adaptive immune responses (19). For example, FOXO3has
been shown to promote the expression of forkhead box
protein3 (Foxp3) in regulatoryT (Treg) cells (20).Moreover,
Caroline et al. reported that FOXO3 enhanced pathogenic
Th1 cell differentiation by inducing eomeseodermin ex-
pression in experimental autoimmune encephalomyelitis
(EAE) (21). In FOXO12/2 FOXO32/2 T cells, genes asso-
ciatedwithTh17cell differentiationwereup-regulatedand
IL-17 production was increased (22), suggesting FOXO3
may be involved in regulating the production of IL-17.
However, whether and how FOXO3 is involved in in-
duction of pathogenic Th17 cells remains unknown.
In this study, we showed that miR-223-3p was signifi-
cantly up-regulated in interphotoreceptor retinoid-binding
protein (IRBP)–specific Th17 cells in EAU. miR-223-3p pos-
itively regulated pathogenic Th17 cell responses by directly
targeting FOXO3, and FOXO3 inhibited IL-17 production
partially via suppression of IL-23R expression. Furthermore,
knockdown of miR-223-3p in T cells dramatically reduced
the severity of EAU and decreased autoreactive Th17 cell
percentages. Our study reveals a previously unknown T-
cell–intrinsicmiR pathway that promotes autoreactive Th17
cells and identifies themiR-223-3p–FOXO3–IL-23R axis as a
potential therapeutic target in uveitis.
MATERIALS AND METHODS
Mice
Pathogen-free female C57BL/6 (B6) (10-wk-old) mice were pur-
chased fromVital River LaboratoryAnimal Technology (Beijing,
China).All animal experiments conformed to theStatement for the
Use of Animals in Ophthalmic and Vision Research (Association for
Research inVisionandOpthalmology,Rockville,MD,USA), and
the protocol was approved by the Institutional Animal Care and
Use Committee of Tianjin Medical University.
Antibodies, cytokines, and peptides
FITC-conjugated or phycoerythrin-conjugated antibodies against
mouse IL-17, IFN-g, CD4, CD11c, and Foxp3 were purchased
fromBioLegend (SanDiego, CA,USA). Antibody to FOXO3was
purchased fromCell Signaling Technology (Danvers,MA,USA),
and antibody to b-actin was purchased from Santa Cruz Bio-
technology (Dallas, TX, USA). Recombinant murine IL-12, IL-23,
IL-4, and GM-CSF were purchased from R&D Systems (Minne-
apolis,MN,USA). A truncated form of IRBP peptide1–20 (aa 1–20
of human IRBP)was synthesized andpurified by SangonBiotech
(Shanghai, China).Mycobacterium tuberculosis strain H37RA was
obtained from Difco Laboratories (Detroit, MI, USA). Pertussis
toxin was purchased from MilliporeSigma (Burlington, MA,
USA).WP1066 (Calbiochem, SanDiego,CA,USA)wasdissolved
in DMSO for storage and use.
T-cell preparation and differentiation
CD4+ T cells were purified from the spleen or draining lymph
nodes of IRBP1–20–immunized B6mice or naivemice by positive
selection using a combination of FITC-conjugated anti-mouse
CD4 antibodies and anti-FITC antibody-coated microbeads
(Miltenyi Biotec, Bergisch Gladbach, Germany), followed by
separation using an autoMACS Separator Column (Miltenyi
Biotec) according to the manufacturer’s protocol. The purity of
the isolated cells was determined by flow cytometric analysis
using phycoerythrin-conjugated anti-CD4 antibodies.
CD4+ T cells were isolated from immunized B6 mice and
cocultured with irradiated antigen-presenting cells (APCs) and
immunized antigen (10 mg/ml) alone (Th0 cells) or in the pres-
ence of IL-12 (10 ng/ml) for Th1 cell polarization or IL-23 (20 ng/
ml) for Th17 cell polarization. Forty-eight hours later, cells were
collected for further analysis.
Generation of bone marrow–derived dendritic cells
Dendritic cells (DCs) were generated from B6 mice as pre-
viously described in refs. 23 and 24. Briefly, bone marrow cells
from B6 mice were isolated and cultured for 6 d in complete
Roswell Park Memorial Institute (RPMI) medium 1640 con-
taining 10 ng/ml GM-CSF (R&D Systems) and 10 ng/ml IL-4
(R&D Systems). DCs were enriched using magnetically acti-
vated cell sorting separation and then treated with miR-223-3p
mimics or control mimics.
EAU induction and evaluation
For active induction of EAU, B6 mice were injected sub-
cutaneously over 6 spots on the tail base and flank with the
emulsion containing equal volumes of 200 mg of IRBP1–20 in PBS
and complete Freund’s adjuvant (CFA) and intraperitoneally
with 350 ng of pertussis toxin (MilliporeSigma). For adoptive
transfer, CD4+ T cells transfected with miR-223-3p inhibitor or
control inhibitor were stimulated with 10 mg/ml of IRBP1–20 for
48 h in the presence of APCs under Th17 cell polarizing condi-
tions. Then, activated T-cell blasts were separated by density
gradient centrifugation (Ficoll; GE Healthcare, Waukesha, WI,
USA) and injected into naive B6 mice.
To examine mice for clinical signs of EAU by indirect
fundoscopy, the pupils were dilated using 1.25% phenyl-
ephrine hydrochloride ophthalmic solution and 0.5% tropi-
camide. Fundoscopic grading of diseasewas performed using
the scoring system previously reported in Thurau et al. (25).
Histopathological evaluation was performed on eye sections
at the end of the experiment, and disease was graded on the
basis of cellular infiltration and structural changes as pre-
viously reported in Zhang et al. (26).
Transfection
miR-223-3p mimics and control mimics, as well as miR-223-3p
inhibitor and control inhibitor, were designed and synthesized
by Gene Pharma (Suzhou, China). DCs and autoreactive CD4+
T cells were transfected with these RNAs at the final concen-
tration of 180 and 300 nM, respectively, using Lipofectamine
2000 Reagent (Thermo Fisher Scientific, Waltham, MA, USA)
according to the manufacturer’s instructions. The FOXO3-
specific small interfering RNAs (siRNAs) were obtained from
Gene Pharma, and the following sequences were used: for
FOXO3 siRNA, 59-UGAUGAUCCACCAAGAGCUCUUGCC-
39(sense) and 59-GGCAAGAGCUCUUGGUGGAUCAUCA-39
(antisense); for control siRNA, 59-UUCUCCGAACGUGUCA-
CGUTT-39 (sense) and59-ACGUGACACGUUCGGAGAATT-39
(antisense). FOXO3 siRNAs were transfected into autoreactive
CD4+ T cells or mouse T-cell lymphoma cell line EL4 (27) at
the final concentration of 200 nM. The overexpression lentiviral
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plasmid pReceiver-Lv201–IL-23R was purchased from Gene-
Copoeia (Rockville, MD, USA). Four micrograms of the
pReceiver-Lv201-IL–23R or the control plasmid were used for
each transfection.
Lentivirus infection
The overexpression lentiviral plasmid pReceiver-Lv201-FOXO3
was purchased from GeneCopoeia. Lentivirus was produced
according to the manufacturer’s instructions. CD4+ T cells iso-
lated from EAUmice were infected with the concentrated lenti-
virus by spinning at 1000 g for 90 min. Subsequently cells were
cultured at 37°C for 24 h, followed by Th17 cell polarizing in-
duction. After 48 h, culture supernatants were collected for
ELISA detection and cells were lysed for real-time quantitative
RT-PCR (qRT-PCR) analysis.
Luciferase reporter assay
Five algorithms (TargetScan, www.targetscan.org; PicTar, http://
pictar.mdc-berlin.de/; Tarbase, www.microrna.gr/tarbase; StarBase,
http://starbase.sysu.edu.cn/index.php; and miRTarBase, http://
miRTarBase.mbc.nctu.edu.tw/) were performed to predict the tar-
gets of miR-223-3p. Luciferase reporter assay was performed to
test the targeted relationship between miR-223-3p and FOXO3.
Firstly, the wild-type (WT) mouse FOXO3 39UTR fragment
containing the putative miR-223-3p binding site or mutant
(Mut) FOXO3 39UTR fragment in the miR-223-3p binding site
was amplified from mouse spleen cDNA and cloned into the
pMIR-Report luciferase miR expression reporter vector (Prom-
ega, Madison, WI, USA). The following sequences of primers
were used: FOXO3 39UTR-WT forward, 59-GGACTAGTAT-
CATCCGTAGTGAACTCATGGATG-39; FOXO3 39UTR-WT re-
verse, 59-CCCAAGCTTTAGAGTTCTGTTCCAC-GGGTAAGG-
G-39; FOXO3 39UTR-Mut forward, 59-GGACTAGTAGCAG-
ACCCTCACGTAACGAGAAGACCTACAGAGAAAACC-39;
FOXO3 39UTR-Mut reverse, 59-CCCAAGCTTTCAAAGGAAA-
CAAACACAAGACGAC-39. Human embryonic kidney 293T cells
(2.5 3 104 cells/well) were cultured in the 96-well plates. Twenty-
four hours later, 75 ng recombinant pMIR-Report vector containing
WT or Mut FOXO3 39UTR and 3.75 ng internal control plasmid
pRL-TK vector (Promega) were cotransfected with miR-223-3p
mimics (100 nM) or control mimics by Lipofectamine 2000 reagent
(Thermo Fisher Scientific). Luciferase activity was measured 48 h
later using the Dual-Luciferase Reporter Assay System (Promega)
according to the manufacturer’s protocol.
miR microarray, gene expression and real-time
qRT-PCR analysis
Total RNA was extracted from naive or autoreactive CD4+
T cells using Trizol reagent (Thermo Fisher Scientific)
according to the manufacturer’s protocol. Purified RNA
was prepared, according to the manufacturer’s instructions
(CapitalBio, Beijing, China) formiR array analysis with an 83
60 K miR Microarray Kit (Agilent Technologies, Santa Clara,
CA, USA). Microarray data were analyzed by the GeneSpring
GX software (Agilent Technologies). The Gene Expression
Omnibus (GEO) database (http://www.ncbi.nlm.nih.gov/geo/)
was sought to obtain gene expression profiles in uveitis pa-
tients and healthy volunteers, and GSE70403, GSE17114,
GSE61399 and GSE10080 were selected for exploring the
correlation of FOXO3 and the pathogenic Th17 pathway.
Real-time qRT-PCR was performed using Sybr Green Master
Mix and an ABI 7900 HT Sequence Detection System (both
from Thermo Fisher Scientific). For miR analysis, reverse
transcription and real-time qRT-PCRprimers formiRs andU6
small nuclear RNA are listed in Table 1. Relative miR ex-
pression was calculated using the 22DDCt cycle threshold
method with the expression of U6 as an internal control. For
mRNA analysis, the gene-specific primers for real-time
qRT-PCR are listed in Table 2. The relative expression level
of mRNA was normalized to that of endogenous gene
glyceraldehyde-3-phosphate dehydrogenase using the method
previously described.
Flow cytometric analysis and ELISA
For intracellular cytokine staining, aliquots of T cells were stim-
ulated with 50 ng/ml of phorbol myristic acetate, 1 mg/ml of
ionomycin, and 1 mg/ml of brefeldin A (MilliporeSigma) for 4 h;
then theywere fixed,permeabilizedovernight, and intracellularly
stained with antibodies. Stained cells were analyzed on a flow
cytometer (FACS Calibur; BD Biosciences, San Jose, CA, USA).
FlowJo software (TreeStar, Ashland, OR, USA) was used to ana-
lyze the acquired data.
The cytokines in the culture supernatants were detected with
commercially available ELISA kits (R&D Systems).
Western blot analysis
EL4 T cells were lysed with RIPA buffer (Solarbio, Beijing,
China) containing PMSF (Solarbio) and phosphatase-
protease inhibitor cocktail (Cell Signaling Technology).
The protein concentration was measured with a Bicincho-
ninic Acid Assay Kit (Solarbio). Equal amounts of protein
(20 mg) were loaded and resolved on SDS-polyacrylamide
gel and transferred onto PVDF membrane. The membranes
were blotted with antibodies specific for FOXO3 (Cell Sig-
naling Technology) or b-actin (Santa Cruz Biotechnology)
and a horseradish peroxidase–linked secondary antibody.
The bands were obtained and analyzed as we previously
described in Xiao et al. (24).
Statistical analysis
All the experiments were repeated 3 times or more. The results
are presented asmeans6 SD, ormeans6 SEM. Statistical analysis
was performed by an unpaired, 2-tailed Student’s t test, 1- or 2-
way ANOVA. A value of P , 0.05 was considered statistically
significant.
RESULTS
miR-223-3p is up-regulated in IRBP-specific
Th17 cells
Given that autoreactive CD4+ T cells play a major role in
autoimmune uveitis, we performed microarray analysis
detecting the miR expression profiles between naive
and autoreactive CD4+ T cells. As shown in Fig. 1A, the
results highlighted up-regulated expression of 2 distinct
miRs (miR-223-3p and miR-210-3p) in autoreactive
CD4+ T cells, which was further confirmed by real-time
qRT-PCR analysis (Fig. 1B). In addition, the data also
revealed significantly up-regulated expression of miR-223-
3p and miR-210-3p in CD4+ T cells from the CFA+ IRBP–
immunized group comparedwith that in CFA-immunized
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mice (Fig. 1B), suggesting possible roles of miR-223-3p and
miR-210-3p in IRBP-specific T-cell responses in EAU. Ki-
netic studies showed that the expression ofmiR-223-3p and
miR-210-3p was dramatically up-regulated in IRBP Th17
cells at d 7 or 13 after immunization, respectively (Fig.
1C–E). The expression of these 2miRs reached amaximum
around d 21 after immunization, followed by a decline.
The kinetics expression changes of miR-223-3p, but not
miR-210-3p, correlated well with EAU disease severity. In
addition,wedetected anup-regulation ofmiR-223-3p and
miR-210-3p expression in uveitogenic T cells in re-
sponse to increasing doses of IRBP1–20 (Fig. 1F, G). To
investigate the expression ofmiR-223-3p andmiR-210-
3p in Th cell subsets, we cultured CD4
+ T cells from
EAU mice with APC and antigen under different Th
cell polarizing conditions in vitro and found signifi-
cantly increased miR-223-3p and miR-210-3p expres-
sion in Th17 cells compared with Th0 cells (Fig. 1H, I).
Additionally, we found that IL-23 induced the ex-
pression of miR-223-3p and miR-210-3p in a dose-
dependent manner. (Fig. 1J, K). Signal transducer and
activator of transcription 3 (STAT3) is one of the major
downstream molecules of IL-23 signaling (28). IL-23 ac-
tivates STAT3 inTh17 cells frompatientswith BD (29). To
further determine whether STAT3 is involved in the
regulation ofmiR-223-3p expression, autoreactive T cells
from EAU mice were pretreated with different doses of
WP1066, a STAT3 inhibitor, and then cocultured with
APC in the presence of IL-23. As shown in Fig. 1L,
WP1066 reversed IL-23–induced up-regulation of miR-
223-3p in a dose-dependent manner (Fig. 1L), indicat-
ing a correlation between IL-23–STAT3 signaling and
miR-223-3p.
miR-223-3p positively regulates pathogenic
Th17 cell responses
Wenext determinedwhethermiR-223-3p andmiR-210-3p
directly regulated Th17 cell responses in vitro. T cells iso-
lated from immunized B6 mice were transfected with
miR-223-3p, miR-210-3p mimics, or control mimics and
then cocultured with APC in the presence of immu-
nized antigen under Th17 cell polarizing conditions. As
shown inFig. 2A,B, ELISAassay revealed thatmiR-223-3p
overexpression significantly promoted IL-17 secretion,
whereas miR-210-3p overexpression had no significant
effect on this cytokine. Because of the stronger effect of
miR-223-3p on IL-17 production, we next focused on
the role of miR-223-3p in the regulation of autoreactive
Th17 cells. Further analysis revealed that miR-223-3p
overexpression significantly increased the percentages of
TABLE 1. Sequences of primers for stem-loop real-time RT-PCR
Primer sequence, 59–39
Name Reverse transcription Forward Reverse
miR-223-3p GTCGTATCCAGTGCAGGGTC
CGAGGTATTCGCACTGGAT
ACGACTGGGGT
GCGCGTGTCAGTTTGTCAAAT
miR-210-3p GTCGTATCCAGTGCAGGGTC
CGAGGTATTCGCACTGGA
TACGACTCAGCC
CGCTGTGCGTGTGACAGC
miR universal AGTGCAGGGTCCGAGGTATT
U6 CGCTTCGGCAGCACATATAC TTCACGAATTTGCGTGTCATC
TABLE 2. Sequences of primers in this study for real-time qRT-PCR
Gene
Primer sequence, 59–39
Forward Reverse
GAPDH CATGGCCTTCCGTGTTCCTA GCGGCACGTCAGATCCA
IL-23p19 CATAGCTGCCCGGGTCTTT GGCACTAAGGGCTCAGTCAGA
IL-12p35 GCGTGGGAGTGGGATGTG GCAAAACGATGGCAAACCA
IL-1b AGTTGACGGACCCCAAAAGA GGACAGCCCAGGTCAAAGG
IL-6 CCACGGCCTTCCCTACTTC TTGGGAGTGGTATCCTCTGTGA
ROR-gt CCTCAGCGCCCTGTGTTTT GCATGCAGCTTTTGCCTGTT
IRF4 TCCTCTGGATGGCTCCAGATGG CACCAAAGCACAGAGTCACCTG
IL-17 CCTGGCGGCTACAGTGAAG TTTGGACACGCTGAGCTTTG
GM-CSF CACCCGCTCACCCATCAC TTCTTTGATGGCCTCTACATGCT
IL-23R CAGAGGACATCCTGCTTCAGGTA GATGGCCAAGAAGACCATTCC
IL-1R1 CCTCGGAATGAGACGATCGA CGTGACGTTGCAGATCAGTTG
IL-22 CTTTCCTGACCAAACTCAGCAA TGGTCGTCACCGCTGATG
Foxp3 CCCTGCCCTTGACCTCAA GCCTCAGTCTCATGGTTTTGG
FOXO3 GGCAAAGCAGACCCTCAAACT TGAGAGCAGATTTGGCAAAGG
GAPDH, glyceraldehyde-3-phosphate dehydrogenase; IRF4, IFN regulatory factor 4.
13954 Vol. 33 December 2019 WEI ET AL.The FASEB Journal x www.fasebj.org
Downloaded from www.fasebj.org by (2607:f010:3fe:ffe2::5c) on February 04, 2020. The FASEB Journal Vol. ${article.issue.getVolume()}, No. ${article.issue.getIssueNumber()}, pp. 13951-13965.
Figure 1. miR-223-3p is highly up-regulated in IRBP-speciﬁc Th17 cells. A, B, D, E) CD4
+ T cells were isolated from EAU mice and
stimulated with IRBP1–20 in the presence of APCs for 48 h in vitro. A) Microarray assay of miR expression proﬁles was performed
comparing CD4+ T cells from naive mice with those from EAU mice. The scatter plot shows the miR normalized probe signal, applying a
cutoff of 2, and highlights up-regulated expression of 2 distinct miRs [Mus musculus (mmu)-miR-223-3p and mmu-miR-210-3p]. B) The
expression of miR-223-3p and miR-210-3p, detected by real-time qRT-PCR, in CD4+ T cells isolated from naive mice, CFA-immunized
mice, and IRBP and CFA–immunized EAU mice. C) Schematic representation of the onset and progression of actively induced EAU. D,
E) Changes in expression levels, detected by real-time qRT-PCR, of miR-223-3p (D) and miR-210-3p (E) at different days following
immunization, normalized to d 0 response. F–K) CD4+ T cells were isolated from immunized mice at d 13 postimmunization and cultured
under indicated conditions. The relative expression of miR-223-3p and miR-210-3p, detected by real-time qRT-PCR, is shown. L) miR-223-
3p expression, detected by real-time qRT-PCR, in autoreactive Th17 cells treated with different doses of WP1066. Data are from 3
independent experiments. The data are presented as means 6 SD. *P , 0.05.
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IL-17–producing T cells comparedwith that in the control
group (26.3 vs. 17.6%, Fig. 2C). In addition, miR-223-3p
overexpression significantly increased the expression of
some pathogenic Th17 cell–related genes—IL-17, retinoic
acid receptor–related orphan receptor-gt (ROR-gt), IL-22,
GM-CSF, and IFN regulatory factor 4—at 48 h after stim-
ulation with IRBP1–20. There was a very small and statis-
tically insignificant increase in IL-23R expression at 48 h
after stimulation (Fig. 2D, E). However, the kinetic data
revealed significantly increased expression of IL-23R at
72 h after stimulation (Fig. 2F).
To further confirm the role ofmiR-223-3p in pathogenic
Th17 cells, CD4
+ T cells isolated from EAU mice were
transfected with miR-223-3p inhibitor or control inhibitor.
As shown in Fig. 2G, miR-223-3p was indeed silenced by
miR-223-3p inhibitor, which was accompanied by a dra-
matically decreased IL-17 production (Fig. 2H) and Th17
cell percentages (19.1 vs. 27.9%, Fig. 2I). In addition,
miR-223-3p knockdown significantly decreased the ex-
pression of IL-17, ROR-gt, IL-22, IL-1 receptor 1 (IL-1R1),
IL-23R, and GM-CSF (Fig. 2J). Collectively, these findings
suggest that miR-223-3p is an important regulator that
positivelymodulates thepathogenicityofTh17 cells in vitro.
miR-223-3p promotes DC-driven
Th17 responses
Previous studies have shown that miR-2232/2 DCs
exhibited decreased ability to drive Th17 cell responses in
EAE (30). TodeterminewhethermiR-223-3p inDCsaffects
IRBP-specific Th17 cell responses in EAU, we cocultured
miR-223-3p mimic– or control mimic–transfected DCs
with autoreactive T cells from immunized B6 mice under
Th17 cell polarizing conditions in the presence of immu-
nized antigen. As shown in Fig. 2K–M, the percentages of
antigen-specific IL-17–producing T cells and the produc-
tion of IL-17 were significantly increased in autoreactive
T cells cocultured with miR-223-3p mimic–transfected
DCs compared with those in T cells cocultured with con-
trol mimic–transfected DCs. These data indicate that
DC-intrinsic miR-223-3p contributes to pathogenic Th17
cell responses in EAU.
IL-1b, IL-6, and IL-23 produced by DCs are critically
involved in pathogenic Th17 cell development (31, 32).
Given the effect of DC-intrinsic miR-223-3p on Th17 cell
responses, we next examined the role of miR-223-3p in
regulation of Th17 cell polarizing cytokine expression in
DCs. DCs pretreated with miR-223-3p mimics or control
mimics were stimulated with LPS for 24 h and then were
subjected to real-time qRT-PCR analysis. As indicated in
Fig. 2N, overexpression of miR-223-3p resulted in signifi-
cantly enhanced IL-1b and IL-23 expression, suggesting
miR-223-3p contributes to the creation of a favorable en-
vironment for pathogenic Th17 cell development.
Silencing miR-223-3p decreases pathogenicity
of Th17 cells
To address the CD4+ T-cell–intrinsic function of miR-223-
3p in EAU,we used an IRBP-specific T-cell–induced EAU
model (Fig. 3A), in which activated T cells cause EAU
when transferred into naive B6 mice (24). For this, T cells
isolated from immunized B6 mice were transfected with
control or miR-223-3p inhibitor, then in vitro activated by
coculturing with APC and immunized antigen. Two days
later, the T cells were collected and transferred into syn-
geneicWTB6mice, and the recipientmiceweremonitored
for the development of EAU. As shown in Fig. 3B, mice
that received Th17 cells transfected with miR-223-3p in-
hibitordeveloped less severeEAU, as comparedwithmice
that received Th17 cells transfected with control inhibitor.
Consistent with the clinical scores, massive infiltration of
inflammatory cells and prominent retinal folds were ob-
served in eyes of mice that received Th17 cells transfected
with control inhibitor relative to that in mice that received
Th17 cells with miR-223-3p inhibitor (Fig. 3C). Compared
with the mean histopathological scores of 1.68 6 0.29 in
control mice, the eyes of mice given transfer of Th17 cells
with miR-223-3p inhibitor exhibited less retinal in-
flammation,withameanscoreof 0.9560.36 (P,0.05; Fig.
3C). Further analysis revealed that T cells isolated from
mice given transfer of T cells with miR-223-3p inhibitor
had dramatically lower percentages of IRBP-specific Th17
and Th1 cells compared with the control group (6.9 vs.
13.3% and 13.5 vs. 19%, respectively; Fig. 3D). Correlating
with the FACS data, the production of IL-17 and IFN-g
was significantly decreased in the T cells from mice re-
ceiving Th17 cells transfected with miR-223-3p inhibitor
compared with that in the control group (Fig. 3E). In ad-
dition, we found that there was a higher percentage of
Foxp3+Treg cells in splenic cells frommicegiven transfer of
Th17cells transfectedwithmiR-223-3p inhibitor than those
from controlmice givenTh17 cells transfectedwith control
inhibitor (Fig. 3F). Collectively, these results indicate that
silencing miR-223-3p decreases pathogenic function of
Th17 cells and thereby ameliorates the development of
EAU.
FOXO3 is a functional target of miR-223-3p
To define the mechanisms by which miR-223-3p modulates
Th17 cell responses, we used a combination of 5 different
computational programs—TargetScan, PicTar, Tarbase,
StarBase, andmiRTarBase—to identify theputative targetsof
miR-223-3p (Fig. 4A). Among the predicted targets, FOXO3,
which plays an important role in regulating T-cell function,
was selected for further study.AsshowninFig. 4B, 39-UTRof
FOXO3 contained 1 highly conserved putative binding ele-
ment for the miR-223-3p.
To determinewhether FOXO3 represents direct targets
of miR-223-3p, we constructed reporter plasmids by
cloning the mouse WT and Mut 39-UTR of FOXO3 genes
into the pMIR-Report luciferase vectors. By cotransfection
of the reporter plasmids and internal control pRL-TK-
Renilla luciferase plasmids with miR-223-3p mimics or
control mimics, we observed that miR-223-3p suppressed
the luciferase activity of the reporter containing the WT,
but not the Mut 39-UTR of FOXO3 (Fig. 4C), suggesting
that miR-223-3p specifically targets FOXO3 and regulates
its expression.
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We next sought to examine whether miR-223-3p
influenced endogenous FOXO3 expression. EL4 T cells
were transfected with miR-223-3p inhibitor or control
inhibitor; the expression of FOXO3 was examined by
real-time qRT-PCR or Western blot. As shown in Fig.
4D, E, the mRNA and protein levels of FOXO3 were
significantly increased in EL4 T cells after transfection
withmiR-223-3p inhibitor comparedwith their control,
indicating that FOXO3 expression could be regulated
by miR-223-3p via translational inhibition and mRNA
degradation. Given the increased levels of miR-223-3p
in mice with EAU and the regulation of FOXO3 ex-
pression bymiR-223-3p,we investigated the expression
levels of FOXO3 in Th17 cells in EAU. The kinetic
studies showed that the expression of FOXO3 dramat-
ically decreased during EAU development (Fig. 4F).
Correlation analysis (33) revealed a negative correlation
between miR-223-3p and FOXO3 expression in Th17
cells in EAU (Fig. 4G). These findings together suggest
that FOXO3 is a functional target of miR-223-3p.
Figure 2. miR-223-3p promotes Th17 cell responses in vitro. A–J) CD4
+ T cells isolated from immunized mice were transfected with
miR-223-3p or miR-210-3p and control mimics (300 nM) (A–F) or inhibitor (300 nM) (G–J) and cocultured with irradiated APCs in
the presence of IRBP1–20 under Th17 cell polarizing conditions. A, B, H) ELISA analysis of IL-17 production in the culture
supernatants. Data are from 3 to 5 independent experiments. C, I) Representative ﬂow cytometry showing IL-17+ T cells. D, E, G)
Real-time qRT-PCR analysis of relative expression of miR-223-3p and Th17 cell–related cytokines, transcription factors, and surface
receptors at 48 h after stimulation with IRBP1–20. F, J) Real-time qRT-PCR analysis of Th17 cell–related gene expression at 72 h after
stimulation. K, L) DCs transfected with miR-223-3p or control mimics were cocultured with CD41 T cells from EAUmice under Th17
cell polarizing conditions. ELISA analysis of IL-17 secretion in the supernatants (K). Representative ﬂow cytometry showing IL-17+
T cells (L). M ) Summary data showing the percentage of IL-17+ T cells. N) DCs pretreated with miR-223-3p mimics or control
mimics were stimulated with 100 ng/ml LPS for 24 h. Real-time qRT-PCR analysis of Th17 cell polarizing cytokine expression. Data
are representative of 3 independent experiments. Ctrl, control. The data are shown as means 6 SD. *P , 0.05, **P , 0.01.
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miR-223-3p promotes pathogenic Th17 cell
responses via suppression of FOXO3
FOXO3 has been demonstrated to control the devel-
opment and function of Treg cells (34, 35). To determine
the role of FOXO3 in Th17 cells, a gain- and loss-of-
function assay was performed using FOXO3 siRNA or
lentivirus-mediated FOXO3 overexpression in EL4 or
autoreactive T cells. As shown in Fig. 5A, B, knock-
down of FOXO3 by FOXO3 siRNA significantly
increased IL-17 production in autoreactive T cells.
Further analysis revealed that the expression of path-
ogenic Th17 cell signature genes (IL-17, ROR-gt, IL-22,
GM-CSF, and IL-1R1) were significantly increased
when FOXO3 was knocked down in both autoreactive
T cells (Fig. 5C) and EL4 T cells (Fig. 5D). In addition,
increased FOXO3 expression mediated by lentivirus
(Fig. 5E) greatly inhibited the expression of IL-17, ROR-
gt, IL-22, GM-CSF, and IL-1R1 in autoreactive Th17
cells (Fig. 5F), and the secretion of IL-17 was also sig-
nificantly reduced after FOXO3 overexpression (Fig.
5G). These data indicate that FOXO3 negatively con-
trols Th17 cell responses, acting as a suppressor of Th17
cell development.
We next examined whether the knockdown of FOXO3
counteracts decreased Th17 cell response induced by
miR-223-3p inhibitor. Cotransfectionwith FOXO3 siRNA,
but not control siRNA, significantly rescued the decrease
in mRNA and protein expression of IL-17 induced by
miR-223-3p inhibitor in both EL4 T cells and autoreactive
Figure 3. Silencing miR-223-3p in CD4+ T cells ameliorates EAU. A) Schematic diagram of EAU induced by adoptive transfer. LN,
lymph node. B) Disease score of adoptive EAU in naive B6 mice (n = 6/group) injected with autoreactive CD4+ T cells transfected
with miR-223-3p (T-miR-223-3p) or control (T-control) inhibitor. C) Hematoxylin and eosin staining and histopathological score
of eyes from the transferred EAU mice (n = 6). Scale bars, 100 mm. D, E) CD4+ T cells were isolated from adoptive EAU mice
(n = 3) and stimulated with IRBP1–20 in the presence of APCs under Th17 cell polarization (Th17 pola) or Th1 cell polarization
(Th1 pola). D) Intracellular cytokine staining for IL-17
1 and IFN-g1 T cells. E) ELISA analysis of IL-17 and IFN-g secretion in the
culture supernatants. F) Flow cytometric analysis of the percentages of CD4+Foxp3+ cells among T cells isolated from the
transferred EAU mice (n = 3). Data are representative of 3 independent experiments. The data are shown as means 6 SD. *P ,
0.05, **P , 0.01.
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Th17 cells (Fig. 5H, I), suggesting miR-223-3p regulates
IL-17 expression through repressing its target FOXO3.
These findings indicate thatmiR-223-3pregulatesTh17cell
function through down-regulation of FOXO3.
IL-23R regulation by miR-223-3p–FOXO3 is
involved in pathogenic function of
autoreactive Th17 cells
IL-23R is critical for Th17 cell–mediated autoimmunity in
vivo (36). To understand the molecular mechanisms by
which FOXO3 suppresses pathogenic Th17 cell responses,
we investigated the involvement of FOXO3 in IL-23R ex-
pression. We observed that knockdown of FOXO3 in
autoreactive T cells resulted in a marked enhancement of
IL-23R expression (Fig. 6A), whereas increased expression
of FOXO3 had an inhibitory effect on the IL-23R expres-
sion (Fig. 6B). These results suggest that FOXO3 is a re-
pressor of IL-23R expression in Th17 cells.
As shown inFig. 2J, IL-23R expressionwas significantly
reduced in miR-223-3p inhibitor–transfected Th17 cells. In
contrast, the time course analysis showed that Th17 cells
transfected with miR-223-3p mimics displayed enhanced
IL-23R expression in comparison with control cells. Fur-
thermore, the knockdown of FOXO3 rescued decreased
IL-23R expression induced by miR-223-3p inhibitor in
Th17 cells (Fig. 6C). Collectively, these data indicate that
the inhibition of FOXO3 by miR-223-3p is one of the
mechanisms for modulating IL-23R expression in Th17
cells.
We next examined whether overexpression of IL-23R
could rectify the defective IL-17 production induced by
miR-223-3p inhibitor in Th17 cells. Autoreactive T cells
were transfected with plasmid control or IL-23R plasmid
or miR-223-3p inhibitor. As shown in Fig. 6D, increased
expressionof IL-23Rdrovemore IL-17production than the
control transfection group, and overexpression of IL-23R
significantly reversed the decreased IL-17 production in-
duced by miR-223-3p inhibitor. Consistent with ELISA
analysis, real-time qRT-PCR analysis showed that the ex-
pression of IL-17, IL-22, and GM-CSF in miR-223-3p
inhibitor–transfected Th17 cells was partially reversed af-
ter overexpression of IL-23R (Fig. 6E–G). These results
indicate that the reduction of IL-23R induced bymiR-223-
3p inhibitor is involved in the decreased pathogenic cy-
tokine expression in Th17 cells.
FOXO3 negatively correlated with Th17 cell
pathway in human uveitis
To extrapolate our results in mice to human subjects, we
searched the Gene Expression Omnibus database for raw
data from gene expression profiles in patientswith uveitis
and healthy volunteers, focusing on correlation of FOXO3
and the pathogenic Th17 cell pathway. As expected, the
expression of FOXO3 was down-regulated in peripheral
blood mononuclear cells (PBMCs) from patients with
uveitis in a clinical data set (GSE70403) (37), whereas the
expression of pathogenic Th17 cell signature genes (in-
cluding IL-17A, IL-17F, IL-1R1, IL-23R, and IL-22) was
up-regulated (Fig. 7A). We further performed the corre-
lation analysis between FOXO3 and Th17 cell signa-
ture genes and found that IL-23R, IL-17A, GM-CSF, and
Figure 4. FOXO3 is a functional target of miR-223-3p. A) Venn diagram analysis of target genes of miR-223-3p as predicted by
TargetScan, miRTarBase, PicTar, Tarbase, and Starbase. B) Conserved miR-223-3p target sites (in red letters) in the 39UTR of
FOXO3 mRNA among multiple species. Mutation of the miR-223-3p binding sites (in blue letters) is shown above. C) Luciferase
activity was measured in 293T cells cotransfected with the reporter containing the WT or Mut 39-UTR of FOXO3 and miR-223-3p
mimics or control mimics. D, E) Real-time qRT-PCR and Western blot analysis of FOXO3 expression in EL4 T cells transfected
with miR-223-3p or control inhibitor. F) Dynamic expression of miR-223-3p and FOXO3 at indicated times after disease
induction was detected by real-time qRT-PCR, normalized to d 0 responses. G) Correlation analysis was performed between miR-
223-3p and FOXO3 expression in Th17 cells during EAU development. P values were calculated by the Pearson correlation test.
Ctrl, control. Data are from 3 to 6 independent experiments. The data are presented as means 6 SD. *P , 0.05, **P , 0.01.
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ROR-gt correlated negativelywith FOXO3 in the data sets
GSE17114 (38), GSE61399 (29), and GSE10080 (Fig. 7B–E).
In addition, in the PBMCs of patients with active BD, hu-
man miR-223 was found to be up-regulated compared
with quiescent BD (39) (Fig. 7F). These results support that
there is a potential crosstalk between the miR-223-3p–
FOXO3–IL-23R axis and pathogenic Th17 cell responses in
human uveitis.
DISCUSSION
Pathogenic Th17 cells are the critical drivers of autoimmune
diseases, and functional regulators of pathogenic Th17 cells
represent potential targets for clinical diagnosis or treatment
of autoimmune disorders (40). Here, we showed that
miR-223-3p positively regulated autoreactive Th17 cell
responses. Using a transferred EAU model for uveitis, we
demonstrated that silencing miR-223-3p in autoreactive
T cells substantially ameliorated EAU pathogenesis, consis-
tent with the positive correlation between miR-223-3p ex-
pressionanddisease inpatientswithuveitis.Mechanistically,
miR-223-3p targeted FOXO3 in autoreactive Th17 cells.
Moreover, FOXO3 negatively regulated pathogenic Th17
cell responses partially via suppressing IL-23R expression.
miR-223-3p has been studied in many fields, particularly
as aparticipant in cancers (41–43), ischemic heart disease (44,
45), pulmonary arterial hypertension (46), rheumatoid ar-
thritis (47), andEAE(30). In this study,we focuson the roleof
miR-223-3p inpathogenicTh17 cell responses inEAU,which
has not yet been clearly illustrated. Our findings that
miR-223-3p is up-regulated in autoreactive CD4+ T cells are
consistent with previous results obtained in other autoim-
mune diseases (48–52). The association among miR-223-3p,
Figure 5. miR-223-3p promotes the pathogenic function of Th17 cells via repression of FOXO3 expression. A–G) EL4 T cells or
autoreactive CD4+ T cells were transfected with FOXO3 siRNA and control siRNA (200 nM) or infected with FOXO3 lentivirus
(LV-FOXO3) or control lentivirus (LV-control). A, E) FOXO3 protein level was analyzed by Western blot. B, G) IL-17 secretion
was determined by ELISA. C, D, F) Relative expression levels of Th17 cell signature genes in EL4 T cells and autoreactive Th17
cells were measured by real-time qRT-PCR. H, I) EL4 T cells or autoreactive CD4+ T cells were transfected with indicated
oligonucleotide. H) Real-time qRT-PCR analysis of IL-17 expression in EL4 T cells. I) ELISA analysis of IL-17 production in
autoreactive Th17 cells. Ctrl, control; siFOXO3, FOXO3 siRNA. Data are representative of at least 3 independent experiments.
The data are shown as means 6 SD. *P , 0.05, **P , 0.01.
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uveitis, and EAU has also been observed. miR-223 has been
shown to be significantly elevated in the retina, and its levels
correspondwith the clinical score of the EAU in rats (14). In
the serumof patientswith noninfectious uveitis,miR-223-3p
was found to be significantly up-regulated compared with
healthy controls (16). In PBMCs of active BD, miR-223-3p
was found to be significantly up-regulated compared with
quiescent BD (39). However, in PBMCs of patients with BD,
miR-223-3pwas found tobe significantly down-regulated as
compared with healthy controls (15). Indeed, our present
findings of miR-223-3p dysregulation are partially in line
with theseprevious studies. It shouldbenoted thatmiR-223-
3p levels changed dynamically at different stages during
EAU development. The expression of miR-223-3p was
up-regulated at the onset and reached themaximumat the
peak stage but was decreased when the disease remitted.
The difference in tissue and cells types, different type of
uveitis, and disease stagemay account for the discrepancy
in these studies.
Development of Th17 cells is programmedby the orphan
nuclear receptorROR-gt. Our data showed thatmiR-223-3p
overexpression in uveitogenic T cells significantly increased
ROR-gt mRNA expression and IL-17 production, suggest-
ing that miR-223-3p concurrently affects autoreactive Th17
cell lineage commitment and function. In addition,miR-223-
3p also significantly up-regulated expression of GM-CSF
and IL-22, which are critical for the pathogenicity of Th17
cells in autoimmunedisease (11). IFN-g–producingTh1 cells
also play a role in the pathogenesis of EAU (53, 54). Here,
we showed that miR-223-3p was also up-regulated in
IRBP-specific Th1 cells, and down-regulation of miR-223-3p
significantly repressed IRBP-specific Th1 cell responses in
vivo. The precise mechanisms underlying the action of
miR-223-3p on Th1 cell responses in EAU are still to be
identified. Given that both Th1 and Th17 pathogenic
T cells contribute to uveitis pathogenesis, manipulation
of miR-223-3p and its signal pathways may offer a new
potential therapeutic strategy for uveitis.
Pathogenic Th17 cell responses are critically regulated
by DC-derived cytokines IL-1b and IL-23 (55). IL-1b is
critical for expansion of pathogenic Th17 cells (56), and
IL-23 stabilizes pathogenic Th17 cell phenotype (7). In this
study, we observed that overexpression of miR-223-3p
significantly increased the expression of IL-1b and IL-23
by DCs, suggesting miR-223-3p may create a favorable
cytokine milieu that supports the generation of patho-
genic Th17 cells. Indeed, we found that miR-223-3p–
overexpressing DCs possessed an enhanced ability to
promote the expansion of IRBP Th17 cells and IL-17 pro-
duction, indicating miR-223-3p also regulates DC-driven
autoreactive Th17 cell responses. Our results here are
further supported by a previous report (ref. 30) showing
thatmiR-223 enhancedmyeloidDC-inducedactivationof
pathogenic Th17 cells in EAE.
In a subsequent study, we found that miR-223-3p and
FOXO3displayedan inversepatternof expression inEAU,
andwe identifiedFOXO3as a target gene ofmiR-223-3p in
autoreactive CD4+ T cells. In agreementwith our findings,
Figure 6. IL-23R is involved in pathogenic Th17 cell responses. A–C ) CD4
+ T cells from immunized B6 mice were
transfected with indicated oligonucleotide (A, C ) or infected with FOXO3 lentivirus (LV-FOXO3) or control lentivirus
(LV-control) (B) and stimulated with the IRBP1–20 and APCs under Th17 cell polarizing conditions. Relative IL-23R mRNA
expression was determined by real-time qRT-PCR. D–G) CD4+ T cells isolated from EAU mice were transfected with
indicated plasmid alone or in combination with miR-223-3p inhibitor and cocultured with irradiated APCs in the presence
of antigen for 72 h. D) IL-17 production was detected by ELISA. E–G) The relative expression of IL-17, IL-22, and GM-CSF
was analyzed by real-time qRT-PCR. Ctrl, control; siFOXO3, FOXO3 siRNA. Data represent means 6 SEM from 3
independent experiments. *P , 0.05.
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miR-223-3p was inversely correlated with FOXO3 in
prostate cancer (57). To further decipher the effect of
FOXO3 on Th17 cell development, a gain- and loss-of-
function assay was conducted using FOXO3 siRNA or
lentivirus-mediated FOXO3 overexpression, and we
demonstrated that FOXO3 negatively regulated the ex-
pression of pathogenic Th17 cell signature genes, in-
dicating that FOXO3mayact as a repressor of autoreactive
Th17 cell generationand function.Our findings that silence
of FOXO3 compromised the activity of miR-223-3p in-
hibitor in Th17 cells indicate the existence of a regulatory
pathway inwhich autoreactive T cells enhance expression
of miR-223-3p, which inhibits FOXO3 expression to pro-
mote Th17 cell responses.
FOXO1 and FOXO3 have been demonstrated to pro-
mote the expression of Foxp3 and Treg cell generation (34).
High expression of miR-223 has been shown to be associ-
ated with lower numbers of Treg cells in tobacco smokers
(58). In this study,we observed that spleen cells frommice
receiving T cells transfected with miR-223-3p inhibitor
displayed a higher percentage of Treg cells, suggesting
decreased miR-223-3p may favor the generation of Treg
cells. Although Th17 and Treg cells play opposite roles in
the regulation of autoimmunity, these 2 subsets can in-
terconvert under specific conditions (59–61). Park et al. (62)
demonstrated that FOXO3 ablation promotes Treg-to-
Th17-like cell conversion, suggestingFOXO3may function
as an intrinsic modulator in T cells that decides between
theTh17andTreg cell choices.Our studieshere suggest that
this lineage choice is also influenced by miR-223-3p:
miR-223-3p biases T cells toward Th17 cell lineage but
inhibits Treg cell differentiation by suppressing FOXO3
expression. Therefore, we proposed that by modulating
FOXO3 expression, miR-223-3p might be a post-
transcriptional regulator controlling Th17-to-Treg cell
plasticity in EAU. FOXO3 also drives pathogenic Th1 cell
differentiation via inducing eomeseodermin expression
in EAE, and deletion of FOXO3 ameliorates EAE (21).
Further studies are needed to investigate the impact of
FOXO3 on IRBP Th1 cell responses and examine its role
in modulation of EAU disease severity.
IL-23R is a key molecule of pathogenic Th17 cell signa-
tures (63). In the present study,we focused on IL-23R as key
target of FOXO3 to explain its regulation on Th17 cell path-
ogenic function.We found that overexpressionof FOXO3 in
Th17 cells led todecreased IL-23Rexpression, indicating that
FOXO3 negatively regulated the expression of IL-23R in
Th17 cells. ROR-gt induces the expression of IL-23R by
bindingdirectly to the Il-23Rpromoter in Th17 cells (64).We
found 1 putative FOXO3 binding element close to the ROR-
gt binding region on the mouse Il-23R locus (Supplemental
Fig. S1A, B), indicating that FOXO3 might inhibit IL-23R
expression via interference of ROR-gt activity in uveitogenic
Th17 cells and therefore control the pathogenicity of Th17
cells. Of note, miR-223-3p directly targeted FOXO3 to pro-
mote IL-17 production, silencing FOXO3 enhanced IL-23R
expression, and IL-23 treatment significantly enhanced the
expression of miR-223-3p and IL-23R (36). Therefore, we
proposed thatmiR-223-3p, togetherwith IL-23,FOXO3,and
IL-23R may form a positive feedback loop to stabilize the
pathogenic Th17 cell phenotype and contribute to constant
IL-17 production in EAU (Fig. 8).
Figure 7. FOXO3 negatively correlates with Th17 cell pathway in human uveitis. A) Expression proﬁles of FOXO3 and
Th17 cell signature genes in PBMCs from BD (n 5 41) vs. those of healthy control by analyzing the clinical dataset
GSE70403. B, C) Correlation of IL-23R and IL-17A gene expression vs. that of FOXO3. Gray and black dots represent
healthy volunteers and BD, respectively. D, E) Correlation of GM-CSF and RORgt gene expression vs. that of FOXO3 in
human PBMCs stimulated with anti-CD3 and -CD28 beads and IL-23. The z score transformed values of published dataset
GSE17114 (B), GSE61399 (C), and GSE10080 (D, E) were used. P values were calculated by the Pearson correlation test
(B–E). F) Analysis of the published clinical data (39) showed up-regulation of Homo sapiens (has)-miR-223 in patients
with active BD. **P , 0.01.
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miRs are essential for pathogenic function of Th17 cells
(65). Various studies have been undertaken to reveal the
regulatory network of miRs in the regulation of patho-
genic Th17 cells in autoimmunity (65–69). Our study here
adds another wrinkle to the relationship between miRs
and pathogenic Th17 cells. Specifically, we have demon-
strated that the suppressionofFOXO3viamiR-223-3p is an
important mechanism by which Th17 cells acquire patho-
genic function in EAU. Thus, themiR-223-3p–FOXO3 axis
may be an important therapeutic target for uveitis.
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